Keyphrases
Lipid Metabolism
100%
Randomized Clinical Trial
100%
Metabolic Modulation
100%
COVID-19
100%
Fenofibrate
100%
Placebo
50%
Peroxisome Proliferator-activated Receptor
20%
Hospitalization
10%
Body Mass Index
10%
Adverse Events
10%
Diabetes
10%
High Incidence
10%
All-cause Mortality
10%
Oxygenation
10%
Gastrointestinal Side Effects
10%
Cytotoxicity
10%
Symptom Onset
10%
Severity Score
10%
Symptom Severity
10%
Time Since Death
10%
Symptom Duration
10%
Replication in Vitro
10%
Ventilation Rate
10%
Clinically Meaningful Outcomes
10%
Human Remains
10%
Nanocrystal Formulation
10%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Clinical Trial
100%
Coronavirinae
100%
Fenofibrate
100%
Diseases
100%
Placebo
50%
Peroxisome Proliferator Activated Receptor Alpha
20%
SARS Coronavirus
20%
Infection
10%
Adverse Event
10%
Gastrointestinal Symptom
10%
Cause of Death
10%
Cytotoxicity
10%